WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement today, applauding the Senate Finance Committee’s 19-9 bipartisan...

WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement today in support of Sen. Debbie Stabenow’s amendment on...

WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond issued the following statement today, responding to the Senate Finance Committee (SFC)...

WASHINGTON—AARP released today its "AARP Asks the Candidates" video series featuring 17 presidential candidates and their plans to address high prescription drug prices, Medicare and Social...

WASHINGTON—Today, AARP announced the largest group of AARP Community Challenge grantees to date. AARP will distribute nearly $1.6 million among 159 grant winners developing “quick-action”...

WASHINGTON—AARP Foundation and the law firm of Garrison, Levin-Epstein, Fitzgerald & Pirrotti, P.C., filed a class action lawsuit on behalf of Yale University employees today, alleging that...

WASHINGTON—AARP Executive Vice President and Chief Advocacy and Engagement Officer Nancy LeaMond released the following statement in response to today’s federal court ruling on the U.S....

WASHINGTON—The prices of widely used specialty prescription drugs grew more than three times faster than general inflation in 2017, according to a new AARP Public Policy Institute report...

WASHINGTON — AARP released the following statement on President Trump’s new executive order requiring doctors, hospitals, and insurers to disclose more information about health care costs. The...

WASHINGTON—Today, the Global Council on Brain Health (GCBH) released a new report that concludes dietary supplements do not improve brain health or prevent cognitive decline, dementia or...